Search results
Results from the Tech24 Deals Content Network
A subsequent approval for similar patients in the EU could push annual sales of the drug past $4 billion in a few years. A buy now. At recent prices, you can scoop up shares of Bristol Myers ...
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
After falling by over 32% in the past 12 months, the pharma titan's shares are trading at a mere 11.9 times forward earnings. ... Pfizer's stock is thus cheap. Bristol Myers Squibb: A high-yield ...
Let's see if Bristol-Myers Squibb Company (BMY) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Friday, Bristol Myers Squibb & Co (NYSE:BMY) posted second-quarter revenues of $12.20 billion, beating the consensus of $11.55 billion, an increase of 9% year-over-year, or 11% when adjusted for ...
For premium support please call: 800-290-4726 more ways to reach us
In the latest trading session, Bristol-Myers Squibb (BMY) closed at $63.50, marking a -0.5% move from the previous day.
Source: Shutterstock. Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for the second quarter of 2019.This is better than the company’s earnings per share of $1.01 from the ...